Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →The Bill & Melinda Gates Foundation, Novo Nordisk Foundation and Wellcome announced a three-year global health research partnership totaling US$300 million on May 6, 2024. Each foundation committed US$100 million. The money is intended to support research and development for solutions that can be accessible and affordable in low- and middle-income countries (LMICs).
What is the $300 million global health partnership?
It is a three-year philanthropic commitment by three foundations to fund global health research and development. The launch announcement was made at the Novo Nordisk Foundation’s Global Science Summit in Denmark. The announcement described the goal as helping produce health solutions that people in LMICs can access and afford. Bill & Melinda Gates Foundation, May 6, 2024
| # | Preview | Product | Price | |
|---|---|---|---|---|
| 1 |
|
Handbook of Global Health | $1,399.99 | Buy on Amazon |
| 2 |
|
Global Health 101: . (Essential Public Health) | $58.65 | Buy on Amazon |
| 3 |
|
Introduction to Global Health | $51.99 | Buy on Amazon |
| 4 |
|
Global Health Care: Issues and Policies: Issues and Policies | $61.90 | Buy on Amazon |
| 5 |
|
Deployed: A Physician on the Front Lines of Global Health | $32.86 | Buy on Amazon |
The name matters: the funder is the Novo Nordisk Foundation, not Novo Nordisk A/S, the pharmaceutical company. “Novo Nordisk” in shorthand references to this partnership can obscure that distinction.
How much is each foundation contributing?
| Foundation | Announced commitment | Term |
|---|---|---|
| Bill & Melinda Gates Foundation | US$100 million | Three-year partnership |
| Novo Nordisk Foundation | US$100 million | Three-year partnership |
| Wellcome | US$100 million | Three-year partnership |
| Total | US$300 million | Three-year partnership |
These figures describe the total announced commitment over three years, not an annual funding level or a claim that all of the money has already been paid out. The partner announcements identify two investments totaling US$120 million; they do not provide a complete disbursement ledger or a full account of all awards.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →#1 Best Overall
What research will it fund?
At launch, the partners named three initial areas for research and innovation:
- The health impacts of climate change.
- Infectious disease and antimicrobial resistance (AMR).
- The relationships among nutrition, immunity, disease and developmental outcomes.
The launch announcement described these as initial priorities, not a definitive list of every project the partnership might support. It also said the partners intended to explore bringing in public and private partners and other philanthropic organizations; that expressed an intention, not confirmation that expansion occurred.
Rank #2
Which investments have the partners announced since launch?
By February 2026, partner announcements had identified two investments of US$60 million each. They target different problems and are described as the partnership’s first and second investments, respectively.
| Investment | Announced amount | Focus | Sequence |
|---|---|---|---|
| Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) | US$60 million over three years | New approaches to antibiotic discovery for Gram-negative bacteria; 18 funded projects led by research teams in 17 countries | First named investment |
| Evaluating AI for Health (EVAH) | US$60 million | Locally led evaluations of AI health tools in LMICs | Second named investment |
The Gates Foundation’s January 22, 2026 announcement called Gr-ADI the partnership’s first investment. Gates Foundation announcement on Gr-ADI On February 20, 2026, Wellcome described EVAH as the second investment; the Novo Nordisk Foundation’s announcement set out its purpose and amount. Novo Nordisk Foundation announcement on EVAH
Rank #3
- Introduction to Global Health is a comprehensive look at today’s most critical global health concerns and the actions that people around the world are taking to solve public health problems and to promote health and wellbeing.
- The Fourth Edition of Introduction to Global Health maintains the clarity and ease of use of the prior edition, while featuring a greater emphasis on the specific interventions that are being implemented to promote longer, healthier lives worldwide and prevent disease, disability, and early death in countries of all income levels.
- Every chapter balances material about pandemics, climate change, and other emerging threats to global public health with evidence of how global health interventions are enabling progress toward achieving health equity.
The two announced investments total US$120 million. The available announcements do not establish the full current portfolio, total disbursements, or measured outcomes, so they cannot show how much of the original US$300 million has been spent or what impact the overall partnership has achieved.
Quick Recap
Rank #4
- Coverage of the COVID-19 pandemic and its impact on global health
- Zika virus and the World Health Organization’s fight against Ebola in the Congo
- New coverage of global infectious diseases and non-communicable diseases
- New chapter on Native American health issues
- New content on global neurological health issues with specific coverage of pain management
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
